Type I interferons (IFNs) play a complex role in immune responses during infections. They are crucial for host defense against viruses but can also cause immune pathology in some acute viral infections, such as influenza, and lead to immune suppression in chronic viral infections, such as lymphocytic choriomeningitis virus. During bacterial infections, type I IFNs may be required early to initiate cell-mediated immune responses. High concentrations can block B cell responses or lead to immunosuppressive molecules and reduce macrophage responsiveness to IFNγ. Recent studies show that prostaglandin E2 and interleukin-1 inhibit type I IFN expression, highlighting the cross-regulatory network during infections. Type I IFNs include IFNα, IFNβ, and other related cytokines. They induce an antiviral state by activating gene transcription that interferes with viral replication. However, they also influence innate and adaptive immune responses to bacteria and other pathogens. The outcome of the IFNα/β response is highly context-dependent. Type I IFN production is triggered by pathogen recognition receptors (PRRs) upon microbial stimulation. Cytosolic receptors like RIG-I and MDA5 recognize RNA, while TLRs recognize different pathogen-associated molecular patterns. These receptors activate signaling pathways that converge on IRF family transcription factors, leading to IFN gene transcription. The IFN signaling pathway involves JAK-STAT signaling, leading to the formation of ISGF3, which activates ISGs that induce an antiviral state. Type I IFNs have protective effects in viral infections by restricting viral replication through ISGs. However, they can also cause immunopathology in severe infections like influenza by inducing TRAIL and DR5, leading to tissue damage. In bacterial infections, IFNs can be protective or detrimental, depending on the pathogen and context. They can enhance immune responses against intracellular bacteria by activating macrophages and promoting antibacterial effector molecules. However, excessive IFN signaling can inhibit antibacterial responses and contribute to immunosuppression or immunopathology. In summary, type I IFNs have diverse roles in immune responses during infections, balancing host protection and immune pathology. Their effects depend on the pathogen, host, and infection context.Type I interferons (IFNs) play a complex role in immune responses during infections. They are crucial for host defense against viruses but can also cause immune pathology in some acute viral infections, such as influenza, and lead to immune suppression in chronic viral infections, such as lymphocytic choriomeningitis virus. During bacterial infections, type I IFNs may be required early to initiate cell-mediated immune responses. High concentrations can block B cell responses or lead to immunosuppressive molecules and reduce macrophage responsiveness to IFNγ. Recent studies show that prostaglandin E2 and interleukin-1 inhibit type I IFN expression, highlighting the cross-regulatory network during infections. Type I IFNs include IFNα, IFNβ, and other related cytokines. They induce an antiviral state by activating gene transcription that interferes with viral replication. However, they also influence innate and adaptive immune responses to bacteria and other pathogens. The outcome of the IFNα/β response is highly context-dependent. Type I IFN production is triggered by pathogen recognition receptors (PRRs) upon microbial stimulation. Cytosolic receptors like RIG-I and MDA5 recognize RNA, while TLRs recognize different pathogen-associated molecular patterns. These receptors activate signaling pathways that converge on IRF family transcription factors, leading to IFN gene transcription. The IFN signaling pathway involves JAK-STAT signaling, leading to the formation of ISGF3, which activates ISGs that induce an antiviral state. Type I IFNs have protective effects in viral infections by restricting viral replication through ISGs. However, they can also cause immunopathology in severe infections like influenza by inducing TRAIL and DR5, leading to tissue damage. In bacterial infections, IFNs can be protective or detrimental, depending on the pathogen and context. They can enhance immune responses against intracellular bacteria by activating macrophages and promoting antibacterial effector molecules. However, excessive IFN signaling can inhibit antibacterial responses and contribute to immunosuppression or immunopathology. In summary, type I IFNs have diverse roles in immune responses during infections, balancing host protection and immune pathology. Their effects depend on the pathogen, host, and infection context.